{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T23:11:14Z","timestamp":1789081874757,"version":"build-2803163510"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":78,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the National Key R&D Program of China","award":["2021YFA1301100, 2021YFA1301104"],"award-info":[{"award-number":["2021YFA1301100, 2021YFA1301104"]}]},{"name":"key laboratory of artificial organs and computational medicine of zhejiang province","award":["SZD2025A009"],"award-info":[{"award-number":["SZD2025A009"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Chronic liver disease (CLD) and its progression to compensated cirrhosis (CC), decompensated cirrhosis (DC), and acute-on-chronic liver failure (ACLF) represent a global health crisis with high mortality. The \u201cgut-liver axis\u201d plays a pivotal role in this progression, yet a systematic characterization of the dynamic microbial evolution across the entire disease spectrum remains elusive. We aimed to systematically characterize the gut microbiota\u2019s dynamic evolution across the spectrum of chronic liver disease and to develop machine-learning models for predicting its critical transitions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In this retrospective cohort study, 947 patients with liver disease (CLD,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009464; CC,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009159; DC,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009260; ACLF,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200964) were enrolled. The relative abundances of 10 dominant gut microbiota\u2014including\n                      <jats:italic>Enterococcus<\/jats:italic>\n                      ,\n                      <jats:italic>Lactobacillus<\/jats:italic>\n                      ,\n                      <jats:italic>Clostridium leptum<\/jats:italic>\n                      ,\n                      <jats:italic>Clostridium butyricum<\/jats:italic>\n                      ,\n                      <jats:italic>Eubacterium rectale<\/jats:italic>\n                      ,\n                      <jats:italic>Faecalibacterium prausnitzii<\/jats:italic>\n                      ,\n                      <jats:italic>Bacteroides<\/jats:italic>\n                      ,\n                      <jats:italic>Enterobacterium<\/jats:italic>\n                      ,\n                      <jats:italic>Bifidobacterium<\/jats:italic>\n                      , and\n                      <jats:italic>Atopobium cluster<\/jats:italic>\n                      \u2014were quantified via qPCR. Random Forest (RF) models were constructed to predict transitions between disease stages. The discriminatory efficacy of the\n                      <jats:italic>Enterococcus\/Eubacterium rectale<\/jats:italic>\n                      Ratio (E\/Er Ratio) was further evaluated using Receiver Operating Characteristic (ROC) analysis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Four distinct dynamic evolutionary patterns were identified. The pro-inflammatory\/anti-inflammatory ratio increased 5.4-fold from CLD to ACLF. Random Forest models accurately predicted all disease transitions. The model for the DC-to-ACLF transition performed best (Area Under the Curve, AUC\u2009=\u20090.961), with clinical parameters (PT, TBil) being the strongest predictors. While the addition of microbial features yielded a modest incremental gain in AUC for the late-stage transition, indices such as the Specific-Butyrate-to-Total ratio were identified as key features, providing critical biological insights into the systemic failure of the gut-liver axis. The E\/Er Ratio further served as a robust, non-invasive marker for identifying critical disease turning points.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Liver disease progression is characterized by a systematic shift in the gut microbiota from an anti-inflammatory, butyrate-rich state to a pro-inflammatory, pathogen-dominant environment. The integrated RF models and the E\/Er Ratio provide a powerful, non-invasive framework for the early prediction and risk stratification of chronic liver disease progression, offering potential targets for gut-centered therapeutic interventions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12967-026-08499-y","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T13:07:04Z","timestamp":1782392824000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dynamic gut microbiota shift in chronic liver disease progression: machine learning models and the E\/Er ratio as a predictive biomarker"],"prefix":"10.1186","volume":"24","author":[{"given":"Dai","family":"Mengting","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Zhaoyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Jingjing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu","family":"Jianbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Tongtong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou","family":"Linling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Jiaying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luo","family":"Jialu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Ping","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6932-7750","authenticated-orcid":false,"given":"Xu","family":"Mingzhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,25]]},"reference":[{"key":"8499_CR1","unstructured":"Sarin SK, Choudhury A, Sharma MK, Maiwall R, Al Mahtab M, Rahman S, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update. Hepatol Int. 2019 July;13(4):353\u201390."},{"issue":"10258","key":"8499_CR2","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"GBD 2019 Diseases and Injuries Collaborators","year":"2020","unstructured":"GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204\u201322.","journal-title":"Lancet"},{"issue":"2","key":"8499_CR3","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.jhep.2022.09.001","volume":"78","author":"C Berasain","year":"2023","unstructured":"Berasain C, Arechederra M, Argem\u00ed J, Fern\u00e1ndez-Barrena MG, Avila MA. Loss of liver function in chronic liver disease: An identity crisis. J Hepatol. 2023;78(2):401\u201314.","journal-title":"J Hepatol"},{"issue":"11","key":"8499_CR4","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1016\/j.cmet.2022.09.017","volume":"34","author":"H Tilg","year":"2022","unstructured":"Tilg H, Adolph TE, Trauner M. Gut-liver axis: Pathophysiological concepts and clinical implications. Cell Metab. 2022;34(11):1700\u201318.","journal-title":"Cell Metab"},{"issue":"3","key":"8499_CR5","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","volume":"72","author":"A Albillos","year":"2020","unstructured":"Albillos A, de Gottardi A, Rescigno M. The gut-liver axis in liver disease: Pathophysiological basis for therapy. J Hepatol. 2020;72(3):558\u201377.","journal-title":"J Hepatol"},{"key":"8499_CR6","doi-asserted-by":"crossref","unstructured":"Pabst O, Hornef MW, Schaap FG, Cerovic V, Clavel T, Bruns T. Gut-liver axis: barriers and functional circuits. Nat Rev Gastroenterol Hepatol. 2023 July;20(7):447\u201361.","DOI":"10.1038\/s41575-023-00771-6"},{"key":"8499_CR7","doi-asserted-by":"crossref","unstructured":"Tripathi A, Debelius J, Brenner DA, Karin M, Loomba R, Schnabl B, et al. The gut-liver axis and the intersection with the microbiome. Nat Rev Gastroenterol Hepatol. 2018 July;15(7):397\u2013411.","DOI":"10.1038\/s41575-018-0011-z"},{"key":"8499_CR8","doi-asserted-by":"crossref","unstructured":"Chopyk DM, Grakoui A. Contribution of the intestinal microbiome and gut barrier to hepatic disorders. Gastroenterology. 2020 Sept;159(3):849\u201363.","DOI":"10.1053\/j.gastro.2020.04.077"},{"issue":"3","key":"8499_CR9","doi-asserted-by":"publisher","first-page":"675","DOI":"10.3390\/microorganisms13030675","volume":"13","author":"E M\u00fcnte","year":"2025","unstructured":"M\u00fcnte E, Viebahn G, Khurana A, Fujiki J, Nakamura T, Lang S, et al. Faecalibacterium prausnitzii Is Associated with Disease Severity in MASLD but Its Supplementation Does Not Improve Diet-Induced Steatohepatitis in Mice. Microorganisms. 2025;13(3):675.","journal-title":"Microorganisms"},{"key":"8499_CR10","first-page":"9726786","volume":"2019","author":"Y Wang","year":"2019","unstructured":"Wang Y, Pan CQ, Xing H. Advances in Gut Microbiota of Viral Hepatitis Cirrhosis. Biomed Res Int. 2019;2019:9726786.","journal-title":"Biomed Res Int"},{"key":"8499_CR11","doi-asserted-by":"crossref","unstructured":"Li J, Xie S, Chen M, Hong C, Chen Y, Lyu F, et al. Panose prevents acute-on-chronic liver failure by reducing bacterial infection in mice. J Clin Invest. 2025 July 15;135 (14):e184653.","DOI":"10.1172\/JCI184653"},{"key":"8499_CR12","doi-asserted-by":"crossref","unstructured":"Lapidot Y, Amir A, Nosenko R, Uzan-Yulzari A, Veitsman E, Cohen-Ezra O, et al. Alterations in the gut microbiome in the progression of cirrhosis to hepatocellular carcinoma. mSystems. 2020 June 16;5(3):e00153\u201320.","DOI":"10.1128\/msystems.00153-20"},{"issue":"6380","key":"8499_CR13","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1126\/science.aar7201","volume":"359","author":"S Manfredo Vieira","year":"2018","unstructured":"Manfredo Vieira S, Hiltensperger M, Kumar V, Zegarra-Ruiz D, Dehner C, Khan N, et al. Translocation of a gut pathobiont drives autoimmunity in mice and humans. Science. 2018;359(6380):1156\u201361.","journal-title":"Science"},{"issue":"12","key":"8499_CR14","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1136\/gutjnl-2016-312729","volume":"65","author":"H Tilg","year":"2016","unstructured":"Tilg H, Cani PD, Mayer EA. Gut microbiome and liver diseases. Gut. 2016;65(12):2035\u201344.","journal-title":"Gut"},{"issue":"7783","key":"8499_CR15","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/s41586-019-1742-x","volume":"575","author":"Y Duan","year":"2019","unstructured":"Duan Y, Llorente C, Lang S, Brandl K, Chu H, Jiang L, et al. Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease. Nature. 2019;575(7783):505\u201311.","journal-title":"Nature"},{"issue":"22","key":"8499_CR16","doi-asserted-by":"publisher","first-page":"14333","DOI":"10.3390\/ijms232214333","volume":"23","author":"AG Abril","year":"2022","unstructured":"Abril AG, Villa TG, S\u00e1nchez-P\u00e9rez \u00c1, Notario V, Carrera M. The Role of the Gallbladder, the Intestinal Barrier and the Gut Microbiota in the Development of Food Allergies and Other Disorders. Int J Mol Sci. 2022;23(22):14333.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"8499_CR17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1017\/S0029665114001463","volume":"74","author":"HJ Flint","year":"2015","unstructured":"Flint HJ, Duncan SH, Scott KP, Louis P. Links between diet, gut microbiota composition and gut metabolism. Proc Nutr Soc. 2015;74(1):13\u201322.","journal-title":"Proc Nutr Soc"},{"key":"8499_CR18","doi-asserted-by":"crossref","unstructured":"Zhao ZH, Xin FZ, Xue Y, Hu Z, Han Y, Ma F, et al. Indole-3-propionic acid inhibits gut dysbiosis and endotoxin leakage to attenuate steatohepatitis in rats. Exp Mol Med. 2019 Sept 10;51(9):1\u201314.","DOI":"10.1038\/s12276-019-0304-5"},{"key":"8499_CR19","doi-asserted-by":"crossref","unstructured":"Leung C, Rivera L, Furness JB, Angus PW. The role of the gut microbiota in NAFLD. Nat Rev Gastroenterol Hepatol. 2016 July;13(7):412\u201325.","DOI":"10.1038\/nrgastro.2016.85"},{"key":"8499_CR20","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3389\/fmicb.2018.00061","volume":"9","author":"ET Saltzman","year":"2018","unstructured":"Saltzman ET, Palacios T, Thomsen M, Vitetta L. Intestinal Microbiome Shifts, Dysbiosis, Inflammation, and Non-alcoholic Fatty Liver Disease. Front Microbiol. 2018;9:61.","journal-title":"Front Microbiol"},{"key":"8499_CR21","doi-asserted-by":"crossref","unstructured":"Kwak JY, Jeon H, Kim SJ, Han JH, Cha RR, Lee SS. Etiology and outcomes of patients with extreme hyperbilirubinemia in korea: a retrospective cohort study. Korean J Gastroenterol 2024 July 25;84 (1):9\u201316.","DOI":"10.4166\/kjg.2024.038"},{"key":"8499_CR22","doi-asserted-by":"publisher","first-page":"8096","DOI":"10.1038\/srep08096","volume":"5","author":"W Jiang","year":"2015","unstructured":"Jiang W, Wu N, Wang X, Chi Y, Zhang Y, Qiu X, et al. Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease. Sci Rep. 2015;5:8096.","journal-title":"Sci Rep"},{"key":"8499_CR23","doi-asserted-by":"crossref","unstructured":"Ren Z, Li A, Jiang J, Zhou L, Yu Z, Lu H, et al. Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma. Gut. 2019 June;68(6):1014\u201323.","DOI":"10.1136\/gutjnl-2017-315084"},{"key":"8499_CR24","doi-asserted-by":"crossref","unstructured":"Zhang X, Yang Y, Gut. The gate and key to brain. Chin Med J (Engl). 2025 Sept 20;138(18):2207\u201319.","DOI":"10.1097\/CM9.0000000000003767"},{"issue":"10","key":"8499_CR25","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1093\/procel\/pwad020","volume":"14","author":"H Zheng","year":"2023","unstructured":"Zheng H, Zhang C, Zhang J, Duan L. Sentinel or accomplice: gut microbiota and microglia crosstalk in disorders of gut-brain interaction. Protein Cell. 2023;14(10):726\u201342.","journal-title":"Protein Cell"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08499-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08499-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08499-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T22:57:32Z","timestamp":1789081052000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08499-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,25]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8499"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08499-y","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,25]]},"assertion":[{"value":"29 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval for this study was obtained from Research Ethics Committee of Shulan (Hangzhou) Hospital (reference number: KY2024136), and all procedures were conducted in accordance with ethical standards. Due to its retrospective nature, the need for written informed consent was waived, and all patient data were de-identified before analysis.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest related to this study.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1171"}}